Cite
Reports Outline Myeloid Leukemia Study Findings from Ariel University (Optimization of Interferon-Alpha and Imatinib Combination Therapy for Chronic Myeloid Leukemia: A Modeling Approach)
MLA
“Reports Outline Myeloid Leukemia Study Findings from Ariel University (Optimization of Interferon-Alpha and Imatinib Combination Therapy for Chronic Myeloid Leukemia: A Modeling Approach).” Stem Cell Week, Jan. 2020, p. 4125. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.612308652&authtype=sso&custid=ns315887.
APA
Reports Outline Myeloid Leukemia Study Findings from Ariel University (Optimization of Interferon-Alpha and Imatinib Combination Therapy for Chronic Myeloid Leukemia: A Modeling Approach). (2020, January 27). Stem Cell Week, 4125.
Chicago
Stem Cell Week. 2020. “Reports Outline Myeloid Leukemia Study Findings from Ariel University (Optimization of Interferon-Alpha and Imatinib Combination Therapy for Chronic Myeloid Leukemia: A Modeling Approach),” January 27. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.612308652&authtype=sso&custid=ns315887.